Public Calendar: June 1 - 7, 2025
This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.
Official Name: Martin A. Makary, M.D., M.P.H., Commissioner for Food and Drugs
Event Date: 06/04/2025
Location: New York, NY
Subject: Jeffries Global Healthcare Conference; Speaker: Fireside Chat
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, academia, government, media, and other registered attendees
Event Date: 06/05/2025
Location: Silver Spring, MD
Subject: CEO Forum: FDA National Listening Tour with Pharmaceutical and Biotech CEOs
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Registered pharmaceutical and biotech CEOs
Official Name: Sara Brenner, M.D., M.P.H., Principal Deputy Commissioner for Food and Drugs
No Significant Event
Official Name: Grace Graham, Deputy Commissioner for Policy, Legislation, and International Affairs
Event Date: 06/04/2025
Location: Silver Spring, MD
Subject: FDA’s 50-State Compounding Meeting; Speaker: Opening Remarks
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Representatives from state governments and the National Association of Boards of Pharmacy (NABP)
Official Name: Kyle Diamantas, J.D., Deputy Commissioner for Human Foods
Event Date: 06/02/2025
Location: Washington, DC
Subject: Human Foods Program Issues of Mutual Interest
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: The Food Beverage Issue Alliance members
Event Date: 06/03/2025
Location: College Park, MD
Subject: Traceability and Front of Package Labeling
FDA Participant/Group: REBECCA BUCKNER; LARRY MORRIS;
Non FDA Participant/Group: Jennifer Hatcher, Leslie Sarasin (Food Industry Association);
Official Name: Barclay Butler, Ph.D., Deputy Commissioner for Operations
No Significant Event
Official Name: Lowell Zeta, J.D., Deputy Commissioner for Strategic Initiatives
No Significant Event
Official Name: Elizabeth Miller, Pharm.D., Acting Associate Commissioner for Inspections and Investigations
No Significant Event
Official Name: Vinayak Prasad, M.D., M.P.H., Director, Center for Biologics Evaluation and Research
No Significant Event
Official Name: Michelle Tarver, M.D., Ph.D., Director, Center for Devices and Radiological Health
Event Date: 06/02/2025
Location: Silver Spring, MD
Subject: General Medical Device Updates
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several Medtronic representatives
Event Date: 06/04/2025
Location: Virtual
Subject: NIH Meeting: Addressing Gaps, Challenges, and Opportunities Related to Data and Metadata Standards for NIDDK Research Priorities; Panelist: Establishment and Adoption of Data and Metadata Standards
FDA Participant/Group: N/A
Non FDA Participant/Group: Members of industry, government, academia, and other stakeholders
Official Name: Jacqueline Corrigan Curay, J.D., M.D., Acting Director, Center for Drug Evaluation and Research
No Significant Event
Official Name: Bret Koplow, Ph.D., J.D., Acting Director, Center for Tobacco Products
No Significant Event
Official Name: Timothy Schell, Ph.D., Acting Director, Center for Veterinary Medicine
Event Date: 06/04/2025
Location: Rockville, MD
Subject: Veterinary Issues of Mutual Interest
FDA Participant/Group: CINDY BURNSTEEL; WILLIAM FLYNN; MATTHEW LUCIA;
Non FDA Participant/Group: Ginny Siller, Martha Scott Poindexter, Mary Jane McNamee, Rachel Cumberbatch, Ron Phillips (Animal Health Institute (AHI));